Sanguine Media Ltd

Sanguine Media Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is effective from July 1, 2026, and will remain in effect until 48 hours after the declaration of its Unaudited Financial Results for the Quarter ended June 30, 2026. The decision aligns with SEBI regulations concerning insider trading. Promoters, Directors, KMPs, Designated Persons, Connected Persons, and their immediate relatives are prohibited from trading during this period. The exact date of the Board Meeting to approve the financial results will be announced later.

Sanguine Media Ltd has informed the stock exchange that its Statement of Deviation or Variation for proceeds of public issue/rights issue/preferential issue, etc., under Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, is not applicable for the quarter and year ended March 31, 2026. This is because the company had no public issue, rights issue, or preferential issue during the said period. The company is adhering to SEBI circulars regarding such disclosures.

Sanguine Media Ltd's Board of Directors has approved the standalone audited financial results for the quarter and financial year ended March 31, 2026. The results, including the Statement of Profit & Loss, Statement of Assets & Liabilities, and Statement of Cash Flow, were audited by K. S. Subrahmanyam & Co. The auditors issued an unmodified opinion. The company reported a net loss of ₹0.70 crore for the quarter ended March 31, 2026, compared to a profit of ₹0.04 crore in the preceding quarter and a loss of ₹2.90 crore in the corresponding quarter of the previous year. For the full financial year, the company reported a net loss of ₹15.98 crore.

Sanguine Media Ltd announced its audited standalone financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the financial statements, including the Statement of Profit & Loss, Statement of Assets & Liabilities, and Statement of Cash Flow. The results were reviewed by the Audit Committee and audited by K. S. Subrahmanyam & Co., who issued an unmodified opinion. The company reported a net loss of ₹0.70 crore for the quarter and ₹15.98 crore for the year ended March 31, 2026. No related party transactions were reported for the financial year.

Sanguine Media Ltd has informed the BSE that the Board of Directors meeting, initially convened on May 29 and reconvened on May 30, 2026, has been adjourned and will reconvene on June 9, 2026. The purpose of the meeting is to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026. The outcome of the adjourned meeting will be submitted to the Stock Exchange upon conclusion.

Sanguine Media Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026, along with the Auditor's Report and Certificate for unmodified opinion. The meeting will also address any other business with the permission of the Chairman.

Sanguine Media Ltd has announced the closure of its trading window for dealing in the securities of the company by promoters, members of the promoter group, directors, KMPs, insiders, designated and connected persons and their immediate relatives. The closure is from Wednesday, April 07, 2026 till 48 hours after the declaration of its Financial Results for the Quarter and Year ended March 31, 2026. This is in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the company's 'Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading in Securities by Designated Persons'. All designated persons, including dependants and immediate relatives, are advised not to enter into any transaction involving the securities of the Company during the aforesaid period of closure of trading window. The date of the Board Meeting in connection with publishing its Financial Results for the quarter and year ended March 31, 2026 will be announced in due course.

Sanguine Media Ltd, in accordance with Regulation 25(3) of the Securities and Exchange Board of India (LODR) Regulations, 2015 and Schedule IV of the Companies Act, 2013, held a separate meeting of the Independent Directors on March 20, 2026. The meeting, which commenced at 03:00 P.M. and concluded at 03:30 P.M., transacted the following business: a) Reviewed the performance of non-independent directors and the board of directors as a whole; b) Reviewed the performance of the chairperson of the listed entity, considering the views of executive directors and non-executive directors; c) Assessed the quality, quantity, and timeliness of flow of information between the management of the listed entity and the board of directors.

Sanguine Media Ltd has announced a board meeting scheduled for 20/03/2026. The agenda includes reviewing the performance of non-independent directors, the board as a whole, and the Chairman of the Company. The meeting will also assess the quantity, quality, and timeliness of information flow. An additional meeting of independent directors will be held to transact this business.

Sanguine Media Ltd has reported its un-audited financial results for the third quarter and nine months ended December 31, 2025. The company's revenue from operations for the quarter is INR 1,000 Lacs and INR 3,225 Lacs for the nine months period. The total income for the quarter is INR 2,100 Lacs and INR 6,023 Lacs for the nine months period. The total expenses for the quarter is INR 2,060 Lacs and INR 5,823 Lacs for the nine months period. The profit before tax for the quarter is INR 40 Lacs and INR 130 Lacs for the nine months period. The profit for the period is INR (13.08) Lacs and INR (15.98) Lacs for the nine months period. The earnings per equity share for continuing operations is INR 0.01 for the quarter and INR 0.02 for the nine months period.